share_log

百奥泰 自愿披露关于与Hikma Pharmaceuticals USA Inc.就BAT2206(乌司奴单抗)注射液签署授权许可与商业化协议收到里程碑付款的公告

Bio-Thera Solutions voluntarily disclosed the announcement about milestone payment received for the authorization and commercialization agreement signed with Hikma Pharmaceuticals USA Inc. regarding BAT2206 (ustekinumab injection).

SZSI ·  Jul 24, 2024 12:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more